This site uses cookies

To give you the best possible experience, the GAM website uses cookies. You can read full information of our cookie use here. Your privacy is important to us and we encourage you to read our privacy policy here.

OK
False df5ddae8-0d2e-46af-bd09-078138376f0a

Christophe Eggmann

Christophe Eggmann - Investment Director


Christophe Eggmann is an Investment Director responsible for GAM’s Healthcare Equity strategy.

Prior to joining GAM Investments in November 2010, he was Head of Equity Research at Julius Baer and equity analyst covering the global healthcare sector. Prior to that, he held various positions as a fund manager and equity analyst at Bank Hofmann, Rothschild Bank and Credit Suisse. Christophe Eggmann holds a Master's in Business Administration and Economics from the University of Neuchâtel and is a CFA Charterholder. He is based in Zurich.

Christophe Eggmann

My Insights

Investment Opinions 8 min read

The US election: What it could mean for…

11 November 2020

With Joe Biden finally confirmed as the 46th US president (Trump legal challenges notwithstanding), GAM Investments fund managers consider the possible implications for their respective asset class.

8 min read
Investment Opinions 4 min read

M&A deals give biotech a shot in the arm

23 October 2020

GAM Investments’ Christophe Eggmann and Jenna Denyes examine the recent uptick in M&A activity in the biotech sector and discuss the importance of identifying innovative companies.

4 min read
Weekly Manager Views 3 min read

Weekly Manager Views: Equities

16 October 2020

At GAM Investments’ Weekly Equities Meeting held on 13 October, four of our managers shared their views on the upcoming US elections and potential market implications.

3 min read
Weekly Manager Views 5 min read

Weekly Manager Views: Equities

10 September 2020

At GAM Investments’ Weekly Equities Meeting held on 8 September, Christophe Eggmann and Jenna Denyes provided an update on the healthcare sector.

5 min read